Overview

Treatment of Orthostatic Hypotension

Status:
Completed
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to try different medications in patients with low blood pressure and other problems with their involuntary (autonomic) nervous system. The pharmacological trials in this study will perhaps lead to more effective treatment. This study consists of single dose trials, dose selection trials, 5-day trials and chronic (approximately 2 months) trials.
Phase:
Phase 3
Details
Lead Sponsor:
Vanderbilt University
Vanderbilt University Medical Center
Treatments:
alpha-Methyltyrosine
Atomoxetine Hydrochloride
Carbidopa
Droxidopa
Levodopa
Methyldopa
Metoclopramide